198 related articles for article (PubMed ID: 29502362)
1. Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis.
Kim J; Kang CI; Gwak GY; Chung DR; Peck KR; Song JH
Korean J Intern Med; 2020 Jan; 35(1):215-221. PubMed ID: 29502362
[TBL] [Abstract][Full Text] [Related]
2. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
[TBL] [Abstract][Full Text] [Related]
4. Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections.
Ding X; Yu Y; Chen M; Wang C; Kang Y; Lou J
BMC Infect Dis; 2019 May; 19(1):463. PubMed ID: 31122192
[TBL] [Abstract][Full Text] [Related]
5. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
[TBL] [Abstract][Full Text] [Related]
6. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.
Chaulk J; Carbonneau M; Qamar H; Keough A; Chang HJ; Ma M; Kumar D; Tandon P
Can J Gastroenterol Hepatol; 2014 Feb; 28(2):83-8. PubMed ID: 24288693
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
[TBL] [Abstract][Full Text] [Related]
8. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
[TBL] [Abstract][Full Text] [Related]
9. Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis.
Chon YE; Kim SU; Lee CK; Park JY; Kim DY; Han KH; Chon CY; Kim S; Jung KS; Ahn SH
Hepatogastroenterology; 2014; 61(136):2283-90. PubMed ID: 25741536
[TBL] [Abstract][Full Text] [Related]
10. Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
Ardolino E; Wang SS; Patwardhan VR
Dig Dis Sci; 2019 Aug; 64(8):2359-2367. PubMed ID: 30761472
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial vs healthcare associated vs community acquired spontaneous bacterial peritonitis: Network meta-analysis.
Iqbal A; Gangwani MK; Beran A; Dahiya DS; Sohail AH; Lee-Smith W; Aziz M; Hassan M
Am J Med Sci; 2023 Oct; 366(4):305-313. PubMed ID: 37394136
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
ELshamy RM; Oda MS; Saeed MA; Ramadan RA
Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):655-663. PubMed ID: 35352700
[TBL] [Abstract][Full Text] [Related]
13. [Spontaneous bacterial peritonitis].
Skladaný Ľ; Kasová S; Purgelová A; Bystrianska N; Adamcová-Selčanová S
Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
[TBL] [Abstract][Full Text] [Related]
14. Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis.
Kim J; Kang CI; Joo EJ; Ha YE; Cho SY; Gwak GY; Chung DR; Peck KR; Song JH
Liver Int; 2014 May; 34(5):695-9. PubMed ID: 24267669
[TBL] [Abstract][Full Text] [Related]
15. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
16. High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?
Oliveira JC; Carrera E; Petry RC; Deutschendorf C; Mantovani A; Barcelos STA; Cassales S; Schacher FC; Lopes AB; Alvares-da-Silva MR
Can J Gastroenterol Hepatol; 2019; 2019():6963910. PubMed ID: 31214551
[TBL] [Abstract][Full Text] [Related]
17. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
[TBL] [Abstract][Full Text] [Related]
19. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
[TBL] [Abstract][Full Text] [Related]
20. ANALYSIS OF HEALTHCARE ASSOCIATED AND HOSPITAL ACQUIRED INFECTIONS IN CRITICALLY ILL PATIENTS WITH CIRRHOSIS.
D'Oliveira RAC; Pereira LCD; Codes L; Rocha MS; Bittencourt PL
Arq Gastroenterol; 2022; 59(1):102-109. PubMed ID: 35442319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
